The European Organisation for Research and Treatment of Cancer (EORTC) provides a pan-European network of experts and the infrastructure for carrying out translational and clinical cancer research across Europe. Members of our NCRI Clinical Studies Groups (CSGs) have been collaborating with the EORTC when necessary, however the connections have primarily been via personal links and a consensus on a single efficient mechanism to explore EORTC clinical trial collaboration has been lacking – until now.
The UK EORTC Liaison Officer, at Cancer Research UK (CRUK), has developed a pathway to highlight the key steps involved in exploring EORTC collaboration when developing a clinical trial (for both UK- and EORTC- initiated studies). These pathways are available to download from both the NCRI CSG website and the EORTC website.
Alongside the pathways a confidentiality framework has been developed to protect against the sharing of study information outside of the collaboration discussions. This framework forms the basis of a ‘conditions of use’ agreement associated with utilising the Collaboration Pathways the details of which are sent on a study-by-study basis.